ATE359766T1 - Pharmazeutische darreichungsformen, welche einen tablettenkern mit einer bruchfestigkeit unter 38n/qcm und einen überzug zum schutz des weichen kerns enthalten - Google Patents

Pharmazeutische darreichungsformen, welche einen tablettenkern mit einer bruchfestigkeit unter 38n/qcm und einen überzug zum schutz des weichen kerns enthalten

Info

Publication number
ATE359766T1
ATE359766T1 AT03706749T AT03706749T ATE359766T1 AT E359766 T1 ATE359766 T1 AT E359766T1 AT 03706749 T AT03706749 T AT 03706749T AT 03706749 T AT03706749 T AT 03706749T AT E359766 T1 ATE359766 T1 AT E359766T1
Authority
AT
Austria
Prior art keywords
tablet core
coating
pharmaceutical dosage
core
qcm
Prior art date
Application number
AT03706749T
Other languages
English (en)
Inventor
Wei Tian
John Langridge
Marshall Whiteman
Original Assignee
Phoqus Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phoqus Pharmaceuticals Ltd filed Critical Phoqus Pharmaceuticals Ltd
Application granted granted Critical
Publication of ATE359766T1 publication Critical patent/ATE359766T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03706749T 2002-02-28 2003-02-28 Pharmazeutische darreichungsformen, welche einen tablettenkern mit einer bruchfestigkeit unter 38n/qcm und einen überzug zum schutz des weichen kerns enthalten ATE359766T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0204772.8A GB0204772D0 (en) 2002-02-28 2002-02-28 Pharmaceutical dosage forms

Publications (1)

Publication Number Publication Date
ATE359766T1 true ATE359766T1 (de) 2007-05-15

Family

ID=9932020

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03706749T ATE359766T1 (de) 2002-02-28 2003-02-28 Pharmazeutische darreichungsformen, welche einen tablettenkern mit einer bruchfestigkeit unter 38n/qcm und einen überzug zum schutz des weichen kerns enthalten

Country Status (12)

Country Link
US (1) US20050142199A1 (de)
EP (1) EP1478350B1 (de)
JP (1) JP2005524654A (de)
AT (1) ATE359766T1 (de)
AU (1) AU2003208461A1 (de)
CA (1) CA2476171A1 (de)
DE (1) DE60313296T2 (de)
ES (1) ES2282604T3 (de)
GB (1) GB0204772D0 (de)
PT (1) PT1478350E (de)
WO (1) WO2003072086A1 (de)
ZA (1) ZA200406194B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040109889A1 (en) 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
JP2007517776A (ja) * 2003-12-09 2007-07-05 スフェリックス， インコーポレイテッド カテコール官能基を有する生体接着性ポリマー
US7553377B1 (en) 2004-04-27 2009-06-30 Advanced Cardiovascular Systems, Inc. Apparatus and method for electrostatic coating of an abluminal stent surface
US7390524B1 (en) 2004-05-20 2008-06-24 Advanced Cardiovascular Systems, Inc. Method for electrostatic spraying of an abluminal stent surface
US20080311191A1 (en) * 2004-08-27 2008-12-18 Avinash Nangia Multi-Layer Tablets and Bioadhesive Dosage Forms
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
EP1830886B1 (de) * 2004-12-27 2016-04-13 Eisai R&D Management Co., Ltd. Verfahren zur stabilisierung eines arzneimittels gegen demenz
EA021960B1 (ru) 2005-12-30 2015-10-30 Крка, Товарна Здравил, Д.Д., Ново Место Таблетка, содержащая фармацевтически приемлемую соль монтелукаста в аморфной форме, и способ ее получения
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
US8426467B2 (en) * 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
US20090004248A1 (en) * 2007-06-29 2009-01-01 Frank Bunick Dual portion dosage lozenge form
CA3062806C (en) * 2008-01-11 2022-09-13 Reata Pharmaceuticals, Inc. Synthetic triterpenoids and methods of use in the treatment of disease
US20100247586A1 (en) * 2009-03-27 2010-09-30 Andreas Hugerth Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties
TWI455733B (zh) * 2009-03-30 2014-10-11 Toray Industries 口腔內崩壞性被覆錠劑
JP5795585B2 (ja) * 2009-08-28 2015-10-14 ハーキュリーズ・インコーポレーテッドＨｅｒｃｕｌｅｓ Ｉｎｃｏｒｐｏｒａｔｅｄ 固体粉末化合物からのフィルムコーティング組成物
US8663671B2 (en) * 2009-11-05 2014-03-04 Philip Morris Usa Inc. Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity
CN102008393B (zh) * 2010-11-12 2012-11-28 罗彦凤 干法包衣设备
AU2018273539B2 (en) 2017-05-22 2024-03-21 Johnson & Johnson Consumer Inc. Lozenge dosage form

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2253164B (en) * 1991-02-22 1994-10-05 Hoechst Uk Ltd Improvements in or relating to electrostatic coating of substrates of medicinal products
EP0620728B1 (de) * 1992-01-13 1997-01-08 Pfizer Inc. Verfahren zur herstellung von tabletten mit hoher festigkeit
US6277409B1 (en) * 2000-02-11 2001-08-21 Mcneil-Ppc, Inc. Protective coating for tablet
GB0117619D0 (en) * 2001-07-19 2001-09-12 Phoqus Ltd Pharmaceutical dosage form

Also Published As

Publication number Publication date
CA2476171A1 (en) 2003-09-04
EP1478350B1 (de) 2007-04-18
PT1478350E (pt) 2007-07-13
AU2003208461A1 (en) 2003-09-09
JP2005524654A (ja) 2005-08-18
EP1478350A1 (de) 2004-11-24
US20050142199A1 (en) 2005-06-30
GB0204772D0 (en) 2002-04-17
DE60313296T2 (de) 2007-12-27
ZA200406194B (en) 2006-06-28
WO2003072086A1 (en) 2003-09-04
ES2282604T3 (es) 2007-10-16
DE60313296D1 (de) 2007-05-31

Similar Documents

Publication Publication Date Title
ATE359766T1 (de) Pharmazeutische darreichungsformen, welche einen tablettenkern mit einer bruchfestigkeit unter 38n/qcm und einen überzug zum schutz des weichen kerns enthalten
AR098808A2 (es) Una forma de dosificación farmacéutica de fusión instantánea que se desintegrará en la boca en un tiempo de 25 segundos
DK1246622T3 (da) Nye substituerede benzimidazol dosisformer og metoder til deres anvendelse
BR0003158A (pt) Formulação de dosagem oral de derretimentoinstantâneo
WO2004056337A3 (en) Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
HUP0000138A2 (hu) Szabályozott hatóanyag-leadású opioid analgetikumokat tartalmazó gyógyászati készítmények
EP1366759A4 (de) Tabletten, die in der mundhöhle schnell zerfallen
ES2099275T3 (es) Comprimido multiparticulas de desleimiento rapido.
ES2036457B1 (es) Forma de dosificacion farmaceutica solida oral de liberacion programada y procedimiento de preparacion.
EP1476138A4 (de) Formulierungen mit modifizierter freisetzung von mindestens einer form von tramadol
MX2009000730A (es) Liberacion controlada de formulaciones y metodos asociados.
EA200700049A1 (ru) Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением
CA2457361A1 (en) Opioid agonist formulations with releasable and sequestered antagonist
AR054782A2 (es) Composiciones farmaceuticas y tabletas que contienen irbesartan en combinacion con un diuretico
NZ314442A (en) Extended release formulation comprising venlafaxine hydrochloride, film coating composition
DE60212734D1 (de) Pharmazeutische Zubereitung enthaltend Doxazosin
TNSN04213A1 (en) High drug load tablet
RS50937B (sr) Farmaceutska kompozicija koja sadrži metformin i glibenklamid za lečenje šećerne bolesti tipa ii
SI1578406T1 (sl) Farmacevtska oblika s prirejenim sproščanjem
TNSN05048A1 (en) Inhalation compositions with high drug ratios
CO5640071A2 (es) Composiciones farmaceuticas de atorvastatina
TW200635617A (en) Multiparticulate pharmaceutical form comprising mucoadhesively formulated nucleic acid active ingredients, and a process for producing the pharmaceutical form
WO2008013833A3 (en) Orally dissolvable/disintegrable lyophilized dosage forms containing protected particles
MXPA02006603A (es) Forma de dosificacion de nucleo suave, de revestimiento fragil.
WO2005007137A3 (de) Ambroxolhaltige tabletten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1478350

Country of ref document: EP

REN Ceased due to non-payment of the annual fee